JAC Advance Access published online on March 1, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl055
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Dipartimento di Scienze e Tecnologie Biomediche, Università di L'Aquila, I-67100 L'Aquila, Italy
* To whom correspondence should be addressed. Objectives: To assess the prevalence and types of genes encoding extended-spectrum Methods: A total of 642 clinical isolates were collected consecutively during a 4 month period (September to December 2004). Resistance or reduced susceptibility to cefotaxime and/or ceftazidime and/or aztreonam was assessed using double disc synergy tests using clavulanic acid, cefotaxime, ceftazidime and aztreonam to identify putative ESBL-producing isolates. The ESBL determinants were characterized by colony blot hybridization, PCR and DNA sequencing. Results: Of the 642 isolates, 220 (34.3%) showed resistance or reduced susceptibility to cefotaxime and/or ceftazidime and/or aztreonam, and 150 (23.4%) were putative ESBL producers. A total of 106 ESBL- producing isolates contained the blaCTX-M-2 gene, and 32 isolates had a novel allele, blaCTX-M-43. blaCTX-M alleles were detected in all P. aeruginosa and Acinetobacter spp. studied. In contrast, only 12 ESBL- producing isolates had blaPER-2, mainly Enterobacteriaceae, although it was also found in a strain of P. aeruginosa. Conclusions: This is the first study on ESBL-producing strains in Bolivia and it reveals a high prevalence of blaCTX-M genes. The PER-2 enzyme was less prevalent, but its gene was detected in several species, including P. aeruginosa, which is consistent with horizontal transfer.
Received December 5, 2005
Revised February 2, 2006
Accepted February 10, 2006
Brief report
Spread of blaCTX-M-type and blaPER-2
Giuseppe Celenza 1,
Cristina Pellegrini 1,
Marisa Caccamo 1,
Bernardetta Segatore 1,
Gianfranco Amicosante 1,
and
Mariagrazia Perilli 1 *
-lactamase genes in clinical isolates from Bolivian hospitals
Mariagrazia Perilli, E-mail: perilli{at}univaq.it
![]()
Abstract
-lactamases (ESBLs) in clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. from Bolivia.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. C. Picao, L. Poirel, A. C. Gales, and P. Nordmann Further Identification of CTX-M-2 Extended-Spectrum {beta}-Lactamase in Pseudomonas aeruginosa Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2225 - 2226. [Full Text] [PDF] |
||||
![]() |
B. Doublet, S. A. Granier, F. Robin, R. Bonnet, L. Fabre, A. Brisabois, A. Cloeckaert, and F.-X. Weill Novel Plasmid-Encoded Ceftazidime-Hydrolyzing CTX-M-53 Extended-Spectrum {beta}-Lactamase from Salmonella enterica Serotypes Westhampton and Senftenberg Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1944 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Celenza, C. Luzi, M. Aschi, B. Segatore, D. Setacci, C. Pellegrini, C. Forcella, G. Amicosante, and M. Perilli Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43 J. Antimicrob. Chemother., November 1, 2008; 62(5): 991 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kiratisin, A. Apisarnthanarak, C. Laesripa, and P. Saifon Molecular Characterization and Epidemiology of Extended-Spectrum- {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-Associated Infection in Thailand, Where the CTX-M Family Is Endemic Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2818 - 2824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Peleg, H. Seifert, and D. L. Paterson Acinetobacter baumannii: Emergence of a Successful Pathogen Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Perez, A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo Global Challenge of Multidrug-Resistant Acinetobacter baumannii Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3471 - 3484. [Full Text] [PDF] |
||||
![]() |
J. Empel, K. Filczak, A. Mrowka, W. Hryniewicz, D. M. Livermore, and M. Gniadkowski Outbreak of Pseudomonas aeruginosa Infections with PER-1 Extended-Spectrum {beta}-Lactamase in Warsaw, Poland: Further Evidence for an International Clonal Complex J. Clin. Microbiol., September 1, 2007; 45(9): 2829 - 2834. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Power, J. Di Conza, M. M. Rodriguez, B. Ghiglione, J. A. Ayala, J. M. Casellas, M. Radice, and G. Gutkind Biochemical Characterization of PER-2 and Genetic Environment of blaPER-2 Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2359 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Endimiani, F. Luzzaro, R. Migliavacca, E. Mantengoli, A. M. Hujer, K. M. Hujer, L. Pagani, R. A. Bonomo, G. M. Rossolini, and A. Toniolo Spread in an Italian Hospital of a Clonal Acinetobacter baumannii Strain Producing the TEM-92 Extended-Spectrum {beta}-Lactamase Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2211 - 2214. [Abstract] [Full Text] [PDF] |
||||



